Product
Medium-dosage COVID-19 Vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase Ⅲb Clinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of COVID-19 Vaccine (Vero Cell), Inactivated Booster Dose in Adults Aged 18 Years and AboveStatus: Withdrawn, Estimated PCD: 2023-02-20